stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G/A - Aligos Therapeutics, Inc. | StockGist | StockGist
Companies
ALGS
SCHEDULE 13G/A
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
ALGS
SCHEDULE 13G/A
SCHEDULE 13G/A
Beneficial Ownership
Amendment
Aligos Therapeutics, Inc.
Filed Nov 14, 2025
Accepted Nov 13, 2025, 7:00 PM ET
ALGS
CIK 0001799448
View on SEC.gov
Company Profile
0000902664-25-005026
Beneficial Ownership Report
Passive Investment
Shares Owned
5,351,374
Reporting Person
Aligos Therapeutics, Inc.
Person Type
IA
CUSIP: 01626L204